The EU seeks comments on the supplementary regulation banning the use of certain antimicrobials in animals or products of animal origin exported to the EU from third countries
On 6 December 2022, the European Commission published a draft authorisation regulation -Ares (2022) 8453372 for comments on supplementary regulation (EU) 2019/6, the Regulation of the European Parliament and of the Council on the Prohibition of the use of certain antimicrobials in animals or products of animal origin exported to the EU from third countries, The feedback period is from December 6, 2022 to January 3, 2023. The main supplementary elements include: (1) The regulation sets out detailed rules prohibiting the use of antimicrobial products intended to promote growth and increase production in animals or products of animal origin exported to the EU from third countries, as well as antimicrobial agents for the treatment of certain human infections; (2) This regulation applies to live food animals whose combined naming codes (" CN codes ") are specified in Chapter 1, Part 2 of Annex I to Regulation (EEC) No2658/87; It also applies to products of animal origin intended for human consumption for which the CN code is specified in Chapters 2 to 5, 15 and 16 of Part II of Annex I and which fall under sections 3501, 3502 and 3504. It does not apply to gelatin and raw materials referred to in point 1, chapter I, section 14, of Annex III of the European Parliament and of the Council of Regulation (EC) No853/2004; (EC) Collagen and its raw materials as described in Point 1, Chapter 1, Section 15 of Annex III No853/2004; (EC) Highly refined products referred to in point 1 of Chapter I, Section 16 of Annex III No853/2004; Wild animals and their derivatives; Insects, frogs, snails and reptiles, including products derived therefrom; Composite products; Animals or animal products not intended for human consumption, unless the destination of the animal or product has not been decided at the time of accession to the EU; Animals or products of animal origin intended for human consumption are used only in transit in the EU and are not placed on the market; Products of animal origin intended for human consumption, samples for product analysis and quality testing, which are not placed on the market; (3) Restrictions on the use of certain antimicrobials in animals entering the EU or in products derived therefrom. Animals and products exported to the EU from third countries must not be used or originate from animals that have been used with any of the following medicines: antimicrobial products used to promote growth or increase production; Antimicrobial products containing antimicrobial agents included in the list of antimicrobial agents prescribed in Implementing Regulation (EU) NO2020/1255 for the treatment of certain human infections; (4) The list of approved third countries, compliance certificates, dizziness requirements, etc.; (5) Entry into force and application The regulation shall enter into force on the twentieth day after its publication in the Official Journal of the European Union. The conditions for the consignment of animals or products into the EU set out in the authorisation Act shall apply 24 months from the date of operation of the implementing Act referred to in Article 6 (1). The regulation should be fully binding and directly applicable to the Member States.
2026-10-17
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
3M, DuPont and Honeywell Must Face Firefighters’ PFAS Turnout-Gear Lawsuit
-
U.S. and China Reach Consensus on More Favorable Tariff Treatment for $30 Billion of Goods Each Way
-
2026 Q1 Chemical Giant Earnings: Supply Contraction, Flat Demand, Full-Scale "Defense Priority"
-
U.S. Section 232 Pharmaceutical Tariffs Take Effect, With 100% Base Rate on Patented Drugs and APIs
-
U.S. and China Open New High-Level Trade Talks on Tariffs, Critical Minerals and Pharma Investment
-
South Korea’s Largest Petrochemical Hub Moves to Cut Cracker Capacity by 40%
-
UK Opens Formal Review of AkzoNobel–Axalta $25 Billion Merger
-
U.S. Congress Passes Bill Authorizing Tariffs of Up to 100% on Major Buyers of Russian Energy
-
U.S. Formally Imposes Antidumping and Countervailing Duty Orders on Chinese L-Lysine
-
South Korea and Japan Launch Energy Supply Chain Cooperation as Hormuz Risks Grow
Recommend Reading
-
FDA Lifts Administrative Stay, Restoring Red No. 3 Ban Timeline for Food and Ingested Drugs
-
FDA Color Policy Uncertainty Opens a New Chapter for Food Ingredient Reform
-
U.S. Sets Preliminary 107.57% Countervailing Rate on Chinese Rubber Accelerator CBS
-
UK Proposes Anti-Dumping Duties of Up to 63.66% on Chinese Rutile Titanium Dioxide
-
EU PIC Amendment Adds Over 30 Chemicals to Control List and Bans 3 POPs Exports
-
Supply Shortage Supports Strong Performance in Chinese Metallurgical Coke Market
-
Formic Acid Moving Averages Set to Cross Upward—Rising Trend May Be About to Begin
-
Geopolitical Expectations Reversal Drags Down Crude Oil, Wednesday's Plunge Exceeds 5%
-
Short-term correction in lithium carbonate, medium to long-term logic remains unchanged
-
High Inventory Levels Put Pressure on DMF Market